UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000006105
Receipt number R000007164
Scientific Title A randomized phase ll study comparing TS-1 + CDDP (SP) therapy and Capecitabine + CDDP (XP) therapy for patients with metastatic lesions after Surgery plus TS-1 therapy (HERBIS-2) (OGSG 1103)
Date of disclosure of the study information 2011/08/08
Last modified on 2022/09/25 21:17:55

No. Disposal Last modified on Item of update
1 Insert 2011/08/02 20:01:56
2 Update 2011/08/11 19:10:57 Division name
3 Update 2011/11/11 18:35:31 Recruitment status
Anticipated trial start date
Last follow-up date
4 Update 2011/11/21 19:06:42 Acronym
Acronym
5 Update 2011/11/22 19:17:58 Last follow-up date
6 Update 2012/06/24 22:38:04 Public title
Public title
Acronym
Acronym
7 Update 2012/06/24 22:42:15 Organization
Organization
Division name
Division name
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
8 Update 2012/09/03 22:29:29 Last follow-up date
9 Update 2014/02/10 13:32:37


Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
10 Update 2014/07/27 23:27:59 Organization
Organization
Address
Address
TEL
Email
Email
Institutions
11 Update 2014/09/04 21:50:05 Institutions
12 Update 2014/11/15 14:58:43 Last follow-up date
13 Update 2015/06/10 00:30:46 Email
Email
14 Update 2016/02/03 07:01:28 Recruitment status
Last follow-up date
15 Update 2016/08/07 19:05:53 Randomization unit
16 Update 2016/08/07 19:07:35 Name of primary person or sponsor
Organization
17 Update 2018/04/30 23:35:56 Email
Email
18 Update 2018/05/10 20:27:59 Email
Email
19 Update 2018/08/02 21:35:43 UMIN ID1
20 Update 2018/08/02 21:38:15 Last follow-up date
21 Update 2018/08/02 21:40:34 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
22 Update 2020/01/05 14:54:43 Date of IRB
23 Update 2020/01/05 15:07:42 Date analysis concluded
24 Update 2020/01/22 21:46:19 Anticipated trial start date
Last follow-up date
25 Update 2020/03/04 22:00:43 Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
26 Update 2020/03/04 22:03:21 Recruitment status
27 Update 2021/08/22 22:29:39 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
28 Update 2021/08/22 22:32:17 Baseline Characteristics
Outcome measures
29 Update 2022/09/25 21:17:55 URL releasing protocol
URL related to results and publications
Date of the first journal publication of results
Participant flow
Participant flow